Literature DB >> 17182568

The critical role of protein kinase C-theta in Fas/Fas ligand-mediated apoptosis.

Santhakumar Manicassamy1, Zuoming Sun.   

Abstract

A functional immune system not only requires rapid expansion of antigenic specific T cells, but also requires efficient deletion of clonally expanded T cells to avoid accumulation of T cells. Fas/Fas ligand (FasL)-mediated apoptosis plays a critical role in the deletion of activated peripheral T cells, which is clearly demonstrated by superantigen-induced expansion and subsequent deletion of T cells. In this study, we show that in the absence of protein kinase C-theta (PKC-theta), superantigen (staphylococcal enterotoxin B)-induced deletion of Vbeta8(+) CD4(+) T cells was defective in PKC-theta(-/-) mice. In response to staphylococcal enterotoxin B challenge, up-regulation of FasL, but not Fas, was significantly reduced in PKC-theta(-/-) mice. PKC-theta is thus required for maximum up-regulation of FasL in vivo. We further show that stimulation of FasL expression depends on PKC-theta-mediated activation of NF-AT pathway. In addition, PKC-theta(-/-) T cells displayed resistance to Fas-mediated apoptosis as well as activation-induced cell death (AICD). In the absence of PKC-theta, Fas-induced activation of apoptotic molecules such as caspase-8, caspase-3, and Bid was not efficient. However, AICD as well as Fas-mediated apoptosis of PKC-theta(-/-) T cells were restored in the presence of high concentration of IL-2, a critical factor required for potentiating T cells for AICD. PKC-theta is thus required for promoting FasL expression and for potentiating Fas-mediated apoptosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17182568     DOI: 10.4049/jimmunol.178.1.312

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

Review 1.  PKC-θ is a drug target for prevention of T cell-mediated autoimmunity and allograft rejection.

Authors:  Myung-Ja Kwon; Ruiqing Wang; Jian Ma; Zuoming Sun
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2010-12       Impact factor: 2.895

2.  Protein kinase C-θ inhibits inducible regulatory T cell differentiation via an AKT-Foxo1/3a-dependent pathway.

Authors:  Jian Ma; Yan Ding; Xianfeng Fang; Ruiqing Wang; Zuoming Sun
Journal:  J Immunol       Date:  2012-04-25       Impact factor: 5.422

3.  Apigenin, a dietary flavonoid, sensitizes human T cells for activation-induced cell death by inhibiting PKB/Akt and NF-kappaB activation pathway.

Authors:  Luting Xu; Li Zhang; Anne M Bertucci; Richard M Pope; Syamal K Datta
Journal:  Immunol Lett       Date:  2008-09-21       Impact factor: 3.685

Review 4.  The emerging role of protein kinase Cθ in cytoskeletal signaling.

Authors:  Izabela Michalczyk; Aleksander F Sikorski; Leszek Kotula; Richard P Junghans; Patrycja M Dubielecka
Journal:  J Leukoc Biol       Date:  2012-11-27       Impact factor: 4.962

5.  A critical role for protein kinase C-theta-mediated T cell survival in cardiac allograft rejection.

Authors:  Santhakumar Manicassamy; Dengping Yin; Zheng Zhang; Luciana L Molinero; Marisa-Luisa Alegre; Zuoming Sun
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

6.  PKCtheta is required for alloreactivity and GVHD but not for immune responses toward leukemia and infection in mice.

Authors:  Javier O Valenzuela; Cristina Iclozan; Mohammad S Hossain; Martin Prlic; Emily Hopewell; Crystina C Bronk; Junmei Wang; Esteban Celis; Robert W Engelman; Bruce R Blazar; Michael J Bevan; Edmund K Waller; Xue-Zhong Yu; Amer A Beg
Journal:  J Clin Invest       Date:  2009-11-09       Impact factor: 14.808

7.  Differential requirement of PKC-theta in the development and function of natural regulatory T cells.

Authors:  Sonal Gupta; Santhakumar Manicassamy; Chenthamarakshan Vasu; Anvita Kumar; Weirong Shang; Zuoming Sun
Journal:  Mol Immunol       Date:  2008-10-08       Impact factor: 4.407

8.  CD8 engineered cytotoxic T cells reprogram melanoma tumor environment.

Authors:  Julie Leignadier; Stephanie Favre; Sanjiv A Luther; Immanuel F Luescher
Journal:  Oncoimmunology       Date:  2015-09-11       Impact factor: 8.110

9.  E3 ubiquitin ligase GRAIL controls primary T cell activation and oral tolerance.

Authors:  Martin A Kriegel; Chozhavendan Rathinam; Richard A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-17       Impact factor: 11.205

10.  Inhibition of diacylglycerol kinase α restores restimulation-induced cell death and reduces immunopathology in XLP-1.

Authors:  Elisa Ruffo; Valeria Malacarne; Sasha E Larsen; Rupali Das; Laura Patrussi; Christoph Wülfing; Christoph Biskup; Senta M Kapnick; Katherine Verbist; Paige Tedrick; Pamela L Schwartzberg; Cosima T Baldari; Ignacio Rubio; Kim E Nichols; Andrew L Snow; Gianluca Baldanzi; Andrea Graziani
Journal:  Sci Transl Med       Date:  2016-01-13       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.